Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Kardiologia Polska

Volumn 69, Issue 4, 2011, Pages 336-343

  Lekston, Andrzej ^a   Tajstra, Mateusz ^a   Ga̧sior, Mariusz ^a   Gierlotka, Marek ^a   Pres, Damian ^a   Hudzik, Bartosz ^a   Trzeciak, Przemysław ^a   Kalarus, Zbigniew ^a   Poloński, Lech ^a   Zembala, Marian ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Multivessel coronary artery disease; Myocardial infarction

Indexed keywords

ABCIXIMAB;

ADULT; ADVERSE OUTCOME; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVESSEL CORONARY DISEASE; PERCUTANEOUS CORONARY INTERVENTION; SINGLE CORONARY VESSEL DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; TREATMENT OUTCOME;

EID: 79955448572     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Poloński L, Ga̧sior M, Gierlotka M et al. Epidemiologia, leczenie i rokowanie w ostrych zespołach wieńcowych na Śla̧sku. Wyniki etapu pilotażowego ogólnopolskiego rejestru ostrych zespołów wieńcowych: PL-ACS. Kardiol Pol, 2005; 62 (suppl. 1): 22-28.
2. O'Keefe JH Jr, Rutherford BD, McConahay DR et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol, 1989; 64: 1221-1230 (Pubitemid 20000066).
3. Waldecker B, Waas W, Haberbosch W et al. Long term follow-up after direct percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol, 1998; 32: 1320-1325 (Pubitemid 28522389).
4. Krikorian RK, Vacek JL, Beauchamp GD. Timing, mode, and predictors of death after direct angioplasty for acute myocardial infarction. Cath Cardiovasc Diag, 1995; 35: 192-196.
5. Grines CL, Cox DA, Stone GW et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med, 1999; 341: 1949-1956 (Pubitemid 30010402).
6. Grines CL, Ellis S, Jones M. Primary coronary angioplasty vs thrombolytic therapy for acute myocardial infarction [MI]: long-term follow-up of 10 randomized trials. Circulation, 1999; 100 (suppl. I): 1499.
7. Lee KL, Woodlief LH, Topol EJ et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation, 1995; 91: 1659-1668.
8. Grines CL, Browne KF, Marco J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med, 1993; 328: 673-679 (Pubitemid 23073368).
9. Sorajja S, Gersh BJ, Cox DA et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J, 2007; 28: 1709-1716 (Pubitemid 47227095).
10. Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF/SCAI/STS//AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol, 2009; 53: 530-553.
11. van der Schaaf RJ, Timmer JR, Ottervanger JP et al. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart, 2006; 92: 1760-1763 (Pubitemid 44851318).
12. Tarantini G, Napodano M, Gasparetto N et al. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodelling in patients with acute myocardial infarction treated by primary coronary angioplasty. Coronary Artery Disease, 2010; 21: 78-86.
13. DeGeare VS, Stone GW, Grines L et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention [a pooled analysis of the primary angioplasty in myocardial infarction trial]. Am J Cardiol, 2000; 86: 30-34 (Pubitemid 30365139).
14. Jaski BE, Cohen JD, Traush J et al. Outcome of urgent percutaneous coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J. 1992; 124: 1427-1433 (Pubitemid 23003572).
15. De Luca G, Suprayanata H, Ottervanger JP et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation, 2004; 109: 1223-1225 (Pubitemid 38372780).
16. Faerman I, Faccio E, Milei J et al. Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes, 1977; 26: 1147-1158.
17. Mehta RH, Ruane TJ, McCargar PA et al. The treatment of elderly diabetic patients with acute myocardial infarction: insight from Michigan's Cooperative Cardiovascular Project. Arch Intern Med, 2000; 160: 1301-1306 (Pubitemid 30252776).
18. Webb JG, Sanborn TA, Sleeper LA et al. SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J, 2001; 141: 964-970.
19. Stein PK, Ehsani AA, Domitrovich PP et al Effect of exercise training on heart rate variability in healthy older adults. Am Heart J, 1999; 138: 567-576 (Pubitemid 29428782).
20. Gibson CM, Ryan KA, Murphy SA et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol, 1999; 34: 974-982 (Pubitemid 29500526).
21. van der Schaaf RJ, Vis MM, Sjauw KD et al. Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol, 2006; 98: 1165-1169 (Pubitemid 44584094).
22. van der Schaaf RJ, Claessen BE, Vis MM et al. Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock. Am J Cardiol, 2010, 105: 955e9.
23. De Luca G, Suryapranata H, van't Hof AW et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation, 2004; 109: 2737-2743.
24. Grines CL, Topol EJ, Califf RM et al. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. Circulation, 1989; 80: 245-253.
25. van Domburg RT, Foley DP, de Feyter PJ et al. Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years follow-up. Eur Heart J, 2001; 22: 934-941 (Pubitemid 32625216).
26. Kalarus Z, Lenarczyk R, Kowalczyk J et al. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am Heart J, 2007; 153: 304-312 (Pubitemid 46096857).
27. Goldstein JA, Demetriou D, Grines CL et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med, 2000; 343: 915-922.
28. Guazzi MD, Bussotti M, Grancini L et al. Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction. Circulation, 1997; 96: 1145-1151 (Pubitemid 27344216).